Testing an annatto-based treatment for statin muscle pain
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This early-stage trial tests whether an annatto-derived product (called GG) can help people who develop new muscle pain after starting or increasing a statin. If you recently noticed statin-related muscle aches, this study may see whether the treatment improves symptoms and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40 or older
- You are taking a statin and have muscle pain (with or without other symptoms)
- Your muscle pain started within 90 days of starting the statin or increasing the dose
- You have not had certain recent medications or supplements (no steroid medication in the past month, and no CoQ10 supplement in the past month)
- You do not have active cancer or major neurological/psychiatric problems, including alcohol or drug abuse
- If you could become pregnant, you can use reliable birth control and you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether dantrolene helps people who get muscle pain or weakness while taking statins. It may help if you have muscle symptoms that started after you began statin therapy.
This study tests whether taking a supplement called geranylgeraniol (GG) can improve muscle health. It is looking for physically active adults who are willing to follow specific dietary rules and avoid certain foods and supplements during the study.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
This trial tests an experimental oral medication called NMD670 for people with myasthenia gravis (MG). It aims to see if the drug is safe and if it helps improve muscle strength and daily function.
Hear when a new Myopathy; Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.